rs28361051

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001365276.2(TNXB):​c.8132T>C​(p.Ile2711Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,612,982 control chromosomes in the GnomAD database, including 130 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0099 ( 15 hom., cov: 32)
Exomes 𝑓: 0.010 ( 115 hom. )

Consequence

TNXB
NM_001365276.2 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.499

Publications

4 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036107898).
BP6
Variant 6-32056597-A-G is Benign according to our data. Variant chr6-32056597-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261167.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0099 (1507/152298) while in subpopulation NFE AF = 0.0124 (844/68014). AF 95% confidence interval is 0.0117. There are 15 homozygotes in GnomAd4. There are 814 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.8132T>C p.Ile2711Thr missense_variant Exon 23 of 44 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.8873T>C p.Ile2958Thr missense_variant Exon 24 of 45 NP_001415264.1
TNXBNM_019105.8 linkc.8132T>C p.Ile2711Thr missense_variant Exon 23 of 44 NP_061978.6 P22105-1O95680Q9Y464O95681

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.8132T>C p.Ile2711Thr missense_variant Exon 23 of 44 NM_001365276.2 ENSP00000496448.1 P22105-3
TNXBENST00000647633.1 linkc.8873T>C p.Ile2958Thr missense_variant Exon 24 of 45 ENSP00000497649.1 A0A3B3ISX9
TNXBENST00000375244.7 linkc.8132T>C p.Ile2711Thr missense_variant Exon 23 of 44 5 ENSP00000364393.3 P22105-3

Frequencies

GnomAD3 genomes
AF:
0.00990
AC:
1507
AN:
152180
Hom.:
15
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.0581
Gnomad AMR
AF:
0.00523
Gnomad ASJ
AF:
0.0331
Gnomad EAS
AF:
0.000963
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.0292
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0124
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.00993
AC:
2436
AN:
245218
AF XY:
0.0104
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00354
Gnomad ASJ exome
AF:
0.0359
Gnomad EAS exome
AF:
0.000391
Gnomad FIN exome
AF:
0.0261
Gnomad NFE exome
AF:
0.0103
Gnomad OTH exome
AF:
0.0112
GnomAD4 exome
AF:
0.0103
AC:
15105
AN:
1460684
Hom.:
115
Cov.:
33
AF XY:
0.0105
AC XY:
7595
AN XY:
726618
show subpopulations
African (AFR)
AF:
0.00146
AC:
49
AN:
33480
American (AMR)
AF:
0.00391
AC:
175
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0342
AC:
893
AN:
26132
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39700
South Asian (SAS)
AF:
0.00502
AC:
433
AN:
86252
European-Finnish (FIN)
AF:
0.0255
AC:
1337
AN:
52470
Middle Eastern (MID)
AF:
0.00503
AC:
29
AN:
5766
European-Non Finnish (NFE)
AF:
0.0105
AC:
11660
AN:
1111818
Other (OTH)
AF:
0.00861
AC:
520
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1037
2073
3110
4146
5183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00990
AC:
1507
AN:
152298
Hom.:
15
Cov.:
32
AF XY:
0.0109
AC XY:
814
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41566
American (AMR)
AF:
0.00523
AC:
80
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0331
AC:
115
AN:
3472
East Asian (EAS)
AF:
0.000965
AC:
5
AN:
5180
South Asian (SAS)
AF:
0.00559
AC:
27
AN:
4826
European-Finnish (FIN)
AF:
0.0292
AC:
310
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0124
AC:
844
AN:
68014
Other (OTH)
AF:
0.00758
AC:
16
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
80
159
239
318
398
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0143
Hom.:
8
Bravo
AF:
0.00739
TwinsUK
AF:
0.00809
AC:
30
ALSPAC
AF:
0.00856
AC:
33
ESP6500AA
AF:
0.00120
AC:
3
ESP6500EA
AF:
0.00985
AC:
50
ExAC
AF:
0.00897
AC:
1081
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.0124
EpiControl
AF:
0.00937

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jul 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TNXB: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome Benign:1
May 27, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Dec 17, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.97
DANN
Benign
0.80
DEOGEN2
Benign
0.066
T;.;T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.033
N
LIST_S2
Benign
0.17
.;T;T;T
MetaRNN
Benign
0.0036
T;T;T;T
MetaSVM
Benign
-0.94
T
PhyloP100
-0.50
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.5
.;.;N;.
REVEL
Benign
0.027
Sift
Benign
0.29
.;.;T;.
Sift4G
Benign
0.18
.;.;T;T
Vest4
0.031
MVP
0.13
ClinPred
0.0041
T
GERP RS
2.0
Varity_R
0.086
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28361051; hg19: chr6-32024374; COSMIC: COSV64483305; API